mitoxantrone has been researched along with B16 Melanoma in 8 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The cytocidal activity of light-activated mitoxantrone in mice bearing B16 melanoma was investigated." | 7.68 | B16 melanoma response in vivo to photochemotherapy with mitoxantrone and red light. ( Andreoni, A; Canti, G; Fabbrocini, G; Mastrocinque, M; Quarto, E, 1991) |
| "Three mouse cancer cell lines [CT26 mouse colon cancer cells, B16 melanoma cells and Lewis lung carcinoma (LLC)], 5 human carcinoma cell lines (human esophageal squamous cell carcinoma cell lines TE8 and HEC46 and the human pancreatic carcinoma cell lines PK-9, AsPC-1 and SUIT-2) and 5 chemotherapeutic agents [mitoxantrone (MIT), mitomycin C(MMC), 5-fluorouracil (5FU), camptothecin (CPT-11) and cisplatin (CDDP)] that are frequently used in a clinical setting for cancer treatment were utilized to investigate the surface expression level of calreticulin and HLA class I after exposure to chemotherapeutic agents." | 3.81 | The key role of calreticulin in immunomodulation induced by chemotherapeutic agents. ( Hirano, S; Kuroda, A; Kuwatani, T; Kyogoku, N; Maki, T; Miyauchi, K; Shichinohe, T; Takeuchi, S; Tsuchikawa, T; Wada, M; Yamamura, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, S | 1 |
| Sharma, P | 1 |
| Kumar, D | 1 |
| Chakraborty, G | 1 |
| Gorain, M | 1 |
| Kundu, GC | 1 |
| Yamamura, Y | 1 |
| Tsuchikawa, T | 1 |
| Miyauchi, K | 1 |
| Takeuchi, S | 1 |
| Wada, M | 1 |
| Kuwatani, T | 1 |
| Kyogoku, N | 1 |
| Kuroda, A | 1 |
| Maki, T | 1 |
| Shichinohe, T | 1 |
| Hirano, S | 1 |
| Shaul, P | 1 |
| Steinbuch, KB | 1 |
| Blacher, E | 1 |
| Stein, R | 1 |
| Fridman, M | 1 |
| Le Coz, V | 1 |
| Zhu, C | 1 |
| Devocelle, A | 1 |
| Vazquez, A | 1 |
| Boucheix, C | 1 |
| Azzi, S | 1 |
| Gallerne, C | 1 |
| Eid, P | 1 |
| Lecourt, S | 1 |
| Giron-Michel, J | 1 |
| Kirshenbaum, MR | 1 |
| Chen, SF | 1 |
| Behrens, CH | 1 |
| Papp, LM | 1 |
| Stafford, MM | 1 |
| Sun, JH | 1 |
| Behrens, DL | 1 |
| Fredericks, JR | 1 |
| Polkus, ST | 1 |
| Sipple, P | 1 |
| Reszka, R | 1 |
| Beck, P | 1 |
| Fichtner, I | 1 |
| Hentschel, M | 1 |
| Richter, J | 1 |
| Kreuter, J | 1 |
| Proske, H | 1 |
| Schachtschabel, DO | 1 |
| Paul, N | 1 |
| Pfab, R | 1 |
| Andreoni, A | 1 |
| Canti, G | 1 |
| Fabbrocini, G | 1 |
| Mastrocinque, M | 1 |
| Quarto, E | 1 |
8 other studies available for mitoxantrone and B16 Melanoma
| Article | Year |
|---|---|
Functional characterization of stromal osteopontin in melanoma progression and metastasis.
Topics: Animals; Carcinogenesis; Cell Communication; Cell Proliferation; Cell Separation; Disease Progressio | 2013 |
The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
Topics: Animals; Antigens, Surface; Antineoplastic Agents; Apoptosis; Calreticulin; Camptothecin; Carcinoma, | 2015 |
Exploring the Effects of Glycosylation and Etherification of the Side Chains of the Anticancer Drug Mitoxantrone.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; DNA; Drug Design; Drug Screening As | 2015 |
IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cell Proliferati | 2016 |
(R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Division; Clinical Trials, Phase I as Topic; Colonic | 1994 |
Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Female; Liposomes; Melanoma, Experimental; Mice; Mito | 1997 |
[Electron microscopic studies on the effects of irradiation and mitoxantrone hydrochloride (Novantrone), alone and in combination, on cells of Harding-Passey melanoma in monolayer culture].
Topics: Animals; Combined Modality Therapy; Melanoma, Experimental; Mice; Mitoxantrone; Radiotherapy Dosage; | 1992 |
B16 melanoma response in vivo to photochemotherapy with mitoxantrone and red light.
Topics: Animals; Light; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitoxantrone; Neoplasm Trans | 1991 |